Rapport Therapeutics insider fund acquires 41,666 shares on 09/12/2025

Rhea-AI Filing Summary

Director Paul Steven M reported purchases of Rapport Therapeutics, Inc. (RAPP) common stock on 09/12/2025. Two purchase entries show 28,284 shares at a weighted average price of $24.4996 and 13,382 shares at a weighted average price of $24.9712, for a combined 41,666 shares. Both holdings are reported as indirect ownership through Paul Capital Strategy III Fund LLC, with the reporting person disclaiming beneficial ownership except to the extent of any pecuniary interest. The filing discloses the price ranges for the multiple trades that produced the weighted averages and is signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Director-associated purchases totaling 41,666 shares were reported, indicating acquisition activity by an insider-affiliated fund
• Full transaction detail provided with weighted average prices and price ranges for the multiple executions

Negative

• None.

Insights

Financial Analyst

Insider purchases reported: a director acquired 41,666 shares indirectly via an affiliated investment fund.

The Form 4 records purchases executed on 09/12/2025 totaling 41,666 common shares acquired at weighted average prices of $24.4996 and $24.9712. Transactions are reported as indirect through Paul Capital Strategy III Fund LLC, which means the reported director is associated with the fund rather than holding the shares directly. The filing provides weighted-average price ranges for the multiple executions and includes the standard disclaimer of beneficial ownership except for any pecuniary interest.

Corporate Governance Expert

Routine SEC disclosure of director-related fund purchases; indirect ownership and disclaimer are properly disclosed.

The filing follows Section 16 reporting conventions by listing transaction codes, weighted-average prices, and the nature of indirect ownership via an affiliated fund. The reporting person checked the director box and filed as one reporting person. The disclosure and signature by an attorney-in-fact indicate procedural compliance; no additional governance actions or departures are reported in this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

PAUL STEVEN M

(Last) (First) (Middle)

RAPPORT THERAPEUTICS, INC.

99 HIGH STREET, SUITE 2100

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rapport Therapeutics, Inc. [ RAPP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		P		28,284	A	$24.4996(1)	28,284	I	By Paul Capital Strategy III Fund LLC(2)
Common Stock	09/12/2025		P		13,382	A	$24.9712(3)	41,666	I	By Paul Capital Strategy III Fund LLC(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.90 to $24.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

2. Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

3. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.90 to $25.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

	/s/ Troy Ignelzi, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Paul Steven M report for RAPP on 09/12/2025?

The filing reports purchases of 28,284 shares at a weighted average price of $24.4996 and 13,382 shares at a weighted average price of $24.9712, totaling 41,666 shares acquired on 09/12/2025.

Are the shares held directly by the director in the RAPP Form 4?

No. Both entries are reported as indirect ownership by Paul Capital Strategy III Fund LLC, and the reporting person disclaims beneficial ownership except for any pecuniary interest.

What price ranges produced the weighted average prices in the RAPP Form 4?

For the 28,284-share block prices ranged from $23.90 to $24.89. For the 13,382-share block prices ranged from $24.90 to $25.00.

Who signed the Form 4 for the reporting person?

The form is signed by /s/ Troy Ignelzi, Attorney-in-Fact on behalf of the reporting person, dated 09/15/2025.